Bovine Blood Plasma Derivatives Industry Research Report 2024

Bovine Blood Plasma Derivatives Industry Research Report 2024


This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.

Highlights

The global Bovine Blood Plasma Derivatives market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Global Bovine Blood Plasma Derivatives key players include Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), etc. Global top three manufacturers hold a share about 30%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia Pacific, both have a share over 45 percent.
In terms of product, FBS is the largest segment, with a share over 65%. And in terms of application, the largest application is Scientific Research, followed by Industrial Production, Feed, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bovine Blood Plasma Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Blood Plasma Derivatives.
The Bovine Blood Plasma Derivatives market size, estimations, and forecasts are provided in terms of output/shipments (K Liters) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bovine Blood Plasma Derivatives market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bovine Blood Plasma Derivatives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac

Product Type Insights

Global markets are presented by Bovine Blood Plasma Derivatives type, along with growth forecasts through 2030. Estimates on production and value are based on the price in the supply chain at which the Bovine Blood Plasma Derivatives are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows production and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Bovine Blood Plasma Derivatives segment by Type

Bovine Serum
FBS
Bovine Serum Albumin
Fibrinogen
Protein Ingredient
Other

Application Insights

This report has provided the market size (production and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Bovine Blood Plasma Derivatives market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Bovine Blood Plasma Derivatives market.
Bovine Blood Plasma Derivatives segment by Application
Scientific Research
Industrial Production
Feed
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast value for 2030.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Bovine Blood Plasma Derivatives market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Blood Plasma Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Bovine Blood Plasma Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Bovine Blood Plasma Derivatives industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Blood Plasma Derivatives.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bovine Blood Plasma Derivatives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bovine Blood Plasma Derivatives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bovine Blood Plasma Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Bovine Blood Plasma Derivatives by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Bovine Serum
1.2.3 FBS
1.2.4 Bovine Serum Albumin
1.2.5 Fibrinogen
1.2.6 Protein Ingredient
1.2.7 Other
2.3 Bovine Blood Plasma Derivatives by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Scientific Research
2.3.3 Industrial Production
2.3.4 Feed
2.3.5 Others
2.4 Global Market Growth Prospects
2.4.1 Global Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2019-2030)
2.4.2 Global Bovine Blood Plasma Derivatives Production Capacity Estimates and Forecasts (2019-2030)
2.4.3 Global Bovine Blood Plasma Derivatives Production Estimates and Forecasts (2019-2030)
2.4.4 Global Bovine Blood Plasma Derivatives Market Average Price (2019-2030)
3 Market Competitive Landscape by Manufacturers
3.1 Global Bovine Blood Plasma Derivatives Production by Manufacturers (2019-2024)
3.2 Global Bovine Blood Plasma Derivatives Production Value by Manufacturers (2019-2024)
3.3 Global Bovine Blood Plasma Derivatives Average Price by Manufacturers (2019-2024)
3.4 Global Bovine Blood Plasma Derivatives Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Bovine Blood Plasma Derivatives Key Manufacturers, Manufacturing Sites & Headquarters
3.6 Global Bovine Blood Plasma Derivatives Manufacturers, Product Type & Application
3.7 Global Bovine Blood Plasma Derivatives Manufacturers, Date of Enter into This Industry
3.8 Global Bovine Blood Plasma Derivatives Market CR5 and HHI
3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Thermo Fisher
4.1.1 Thermo Fisher Bovine Blood Plasma Derivatives Company Information
4.1.2 Thermo Fisher Bovine Blood Plasma Derivatives Business Overview
4.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
4.1.4 Thermo Fisher Product Portfolio
4.1.5 Thermo Fisher Recent Developments
4.2 GE Healthcare
4.2.1 GE Healthcare Bovine Blood Plasma Derivatives Company Information
4.2.2 GE Healthcare Bovine Blood Plasma Derivatives Business Overview
4.2.3 GE Healthcare Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
4.2.4 GE Healthcare Product Portfolio
4.2.5 GE Healthcare Recent Developments
4.3 Merck (Sigma-Aldrich)
4.3.1 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Company Information
4.3.2 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Business Overview
4.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
4.3.4 Merck (Sigma-Aldrich) Product Portfolio
4.3.5 Merck (Sigma-Aldrich) Recent Developments
4.4 Moregate BioTech
4.4.1 Moregate BioTech Bovine Blood Plasma Derivatives Company Information
4.4.2 Moregate BioTech Bovine Blood Plasma Derivatives Business Overview
4.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
4.4.4 Moregate BioTech Product Portfolio
4.4.5 Moregate BioTech Recent Developments
4.5 Gemini
4.5.1 Gemini Bovine Blood Plasma Derivatives Company Information
4.5.2 Gemini Bovine Blood Plasma Derivatives Business Overview
4.5.3 Gemini Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
4.5.4 Gemini Product Portfolio
4.5.5 Gemini Recent Developments
4.6 Atlanta Biologicals
4.6.1 Atlanta Biologicals Bovine Blood Plasma Derivatives Company Information
4.6.2 Atlanta Biologicals Bovine Blood Plasma Derivatives Business Overview
4.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
4.6.4 Atlanta Biologicals Product Portfolio
4.6.5 Atlanta Biologicals Recent Developments
4.7 Tissue Culture Biologicals
4.7.1 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Company Information
4.7.2 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Business Overview
4.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
4.7.4 Tissue Culture Biologicals Product Portfolio
4.7.5 Tissue Culture Biologicals Recent Developments
4.8 Bovogen
4.8.1 Bovogen Bovine Blood Plasma Derivatives Company Information
4.8.2 Bovogen Bovine Blood Plasma Derivatives Business Overview
4.8.3 Bovogen Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
4.8.4 Bovogen Product Portfolio
4.8.5 Bovogen Recent Developments
4.9 Biowest
4.9.1 Biowest Bovine Blood Plasma Derivatives Company Information
4.9.2 Biowest Bovine Blood Plasma Derivatives Business Overview
4.9.3 Biowest Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
4.9.4 Biowest Product Portfolio
4.9.5 Biowest Recent Developments
4.10 Internegocios
4.10.1 Internegocios Bovine Blood Plasma Derivatives Company Information
4.10.2 Internegocios Bovine Blood Plasma Derivatives Business Overview
4.10.3 Internegocios Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
4.10.4 Internegocios Product Portfolio
4.10.5 Internegocios Recent Developments
7.11 RMBIO
7.11.1 RMBIO Bovine Blood Plasma Derivatives Company Information
7.11.2 RMBIO Bovine Blood Plasma Derivatives Business Overview
4.11.3 RMBIO Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
7.11.4 RMBIO Product Portfolio
7.11.5 RMBIO Recent Developments
7.12 Biological Industries
7.12.1 Biological Industries Bovine Blood Plasma Derivatives Company Information
7.12.2 Biological Industries Bovine Blood Plasma Derivatives Business Overview
7.12.3 Biological Industries Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
7.12.4 Biological Industries Product Portfolio
7.12.5 Biological Industries Recent Developments
7.13 VWR
7.13.1 VWR Bovine Blood Plasma Derivatives Company Information
7.13.2 VWR Bovine Blood Plasma Derivatives Business Overview
7.13.3 VWR Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
7.13.4 VWR Product Portfolio
7.13.5 VWR Recent Developments
7.14 Corning
7.14.1 Corning Bovine Blood Plasma Derivatives Company Information
7.14.2 Corning Bovine Blood Plasma Derivatives Business Overview
7.14.3 Corning Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
7.14.4 Corning Product Portfolio
7.14.5 Corning Recent Developments
7.15 Serana
7.15.1 Serana Bovine Blood Plasma Derivatives Company Information
7.15.2 Serana Bovine Blood Plasma Derivatives Business Overview
7.15.3 Serana Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
7.15.4 Serana Product Portfolio
7.15.5 Serana Recent Developments
7.16 Lanzhou Minhai
7.16.1 Lanzhou Minhai Bovine Blood Plasma Derivatives Company Information
7.16.2 Lanzhou Minhai Bovine Blood Plasma Derivatives Business Overview
7.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
7.16.4 Lanzhou Minhai Product Portfolio
7.16.5 Lanzhou Minhai Recent Developments
7.17 Zhejiang Tianhang Biotechnology
7.17.1 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Company Information
7.17.2 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Business Overview
7.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
7.17.4 Zhejiang Tianhang Biotechnology Product Portfolio
7.17.5 Zhejiang Tianhang Biotechnology Recent Developments
7.18 ExCell Bio
7.18.1 ExCell Bio Bovine Blood Plasma Derivatives Company Information
7.18.2 ExCell Bio Bovine Blood Plasma Derivatives Business Overview
7.18.3 ExCell Bio Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
7.18.4 ExCell Bio Product Portfolio
7.18.5 ExCell Bio Recent Developments
7.19 Jin Yuan Kang
7.19.1 Jin Yuan Kang Bovine Blood Plasma Derivatives Company Information
7.19.2 Jin Yuan Kang Bovine Blood Plasma Derivatives Business Overview
7.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
7.19.4 Jin Yuan Kang Product Portfolio
7.19.5 Jin Yuan Kang Recent Developments
7.20 American Protein Company
7.20.1 American Protein Company Bovine Blood Plasma Derivatives Company Information
7.20.2 American Protein Company Bovine Blood Plasma Derivatives Business Overview
7.20.3 American Protein Company Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
7.20.4 American Protein Company Product Portfolio
7.20.5 American Protein Company Recent Developments
7.21 Sonac
7.21.1 Sonac Bovine Blood Plasma Derivatives Company Information
7.21.2 Sonac Bovine Blood Plasma Derivatives Business Overview
7.21.3 Sonac Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2019-2024)
7.21.4 Sonac Product Portfolio
7.21.5 Sonac Recent Developments
5 Global Bovine Blood Plasma Derivatives Production by Region
5.1 Global Bovine Blood Plasma Derivatives Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
5.2 Global Bovine Blood Plasma Derivatives Production by Region: 2019-2030
5.2.1 Global Bovine Blood Plasma Derivatives Production by Region: 2019-2024
5.2.2 Global Bovine Blood Plasma Derivatives Production Forecast by Region (2025-2030)
5.3 Global Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
5.4 Global Bovine Blood Plasma Derivatives Production Value by Region: 2019-2030
5.4.1 Global Bovine Blood Plasma Derivatives Production Value by Region: 2019-2024
5.4.2 Global Bovine Blood Plasma Derivatives Production Value Forecast by Region (2025-2030)
5.5 Global Bovine Blood Plasma Derivatives Market Price Analysis by Region (2019-2024)
5.6 Global Bovine Blood Plasma Derivatives Production and Value, YOY Growth
5.6.1 North America Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2019-2030)
5.6.2 Europe Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2019-2030)
5.6.3 China Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2019-2030)
5.6.4 Japan Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2019-2030)
5.6.5 Australia Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2019-2030)
6 Global Bovine Blood Plasma Derivatives Consumption by Region
6.1 Global Bovine Blood Plasma Derivatives Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
6.2 Global Bovine Blood Plasma Derivatives Consumption by Region (2019-2030)
6.2.1 Global Bovine Blood Plasma Derivatives Consumption by Region: 2019-2030
6.2.2 Global Bovine Blood Plasma Derivatives Forecasted Consumption by Region (2025-2030)
6.3 North America
6.3.1 North America Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Bovine Blood Plasma Derivatives Consumption by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Bovine Blood Plasma Derivatives Consumption by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.5 Asia Pacific
6.5.1 Asia Pacific Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Bovine Blood Plasma Derivatives Consumption by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 China Taiwan
6.5.7 Southeast Asia
6.5.8 India
6.5.9 Australia
6.6 Latin America, Middle East & Africa
6.6.1 Latin America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 Latin America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.5 GCC Countries
7 Segment by Type
7.1 Global Bovine Blood Plasma Derivatives Production by Type (2019-2030)
7.1.1 Global Bovine Blood Plasma Derivatives Production by Type (2019-2030) & (K Liters)
7.1.2 Global Bovine Blood Plasma Derivatives Production Market Share by Type (2019-2030)
7.2 Global Bovine Blood Plasma Derivatives Production Value by Type (2019-2030)
7.2.1 Global Bovine Blood Plasma Derivatives Production Value by Type (2019-2030) & (US$ Million)
7.2.2 Global Bovine Blood Plasma Derivatives Production Value Market Share by Type (2019-2030)
7.3 Global Bovine Blood Plasma Derivatives Price by Type (2019-2030)
8 Segment by Application
8.1 Global Bovine Blood Plasma Derivatives Production by Application (2019-2030)
8.1.1 Global Bovine Blood Plasma Derivatives Production by Application (2019-2030) & (K Liters)
8.1.2 Global Bovine Blood Plasma Derivatives Production by Application (2019-2030) & (K Liters)
8.2 Global Bovine Blood Plasma Derivatives Production Value by Application (2019-2030)
8.2.1 Global Bovine Blood Plasma Derivatives Production Value by Application (2019-2030) & (US$ Million)
8.2.2 Global Bovine Blood Plasma Derivatives Production Value Market Share by Application (2019-2030)
8.3 Global Bovine Blood Plasma Derivatives Price by Application (2019-2030)
9 Value Chain and Sales Channels Analysis of the Market
9.1 Bovine Blood Plasma Derivatives Value Chain Analysis
9.1.1 Bovine Blood Plasma Derivatives Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Bovine Blood Plasma Derivatives Production Mode & Process
9.2 Bovine Blood Plasma Derivatives Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Bovine Blood Plasma Derivatives Distributors
9.2.3 Bovine Blood Plasma Derivatives Customers
10 Global Bovine Blood Plasma Derivatives Analyzing Market Dynamics
10.1 Bovine Blood Plasma Derivatives Industry Trends
10.2 Bovine Blood Plasma Derivatives Industry Drivers
10.3 Bovine Blood Plasma Derivatives Industry Opportunities and Challenges
10.4 Bovine Blood Plasma Derivatives Industry Restraints
11 Report Conclusion
12 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Bovine Blood Plasma Derivatives Production by Manufacturers (K Liters) & (2019-2024)
Table 6. Global Bovine Blood Plasma Derivatives Production Market Share by Manufacturers
Table 7. Global Bovine Blood Plasma Derivatives Production Value by Manufacturers (US$ Million) & (2019-2024)
Table 8. Global Bovine Blood Plasma Derivatives Production Value Market Share by Manufacturers (2019-2024)
Table 9. Global Bovine Blood Plasma Derivatives Average Price (USD/L) of Key Manufacturers (2019-2024)
Table 10. Global Bovine Blood Plasma Derivatives Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Bovine Blood Plasma Derivatives Manufacturers, Product Type & Application
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Bovine Blood Plasma Derivatives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2023)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 15. Thermo Fisher Bovine Blood Plasma Derivatives Company Information
Table 16. Thermo Fisher Business Overview
Table 17. Thermo Fisher Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 18. Thermo Fisher Product Portfolio
Table 19. Thermo Fisher Recent Developments
Table 20. GE Healthcare Bovine Blood Plasma Derivatives Company Information
Table 21. GE Healthcare Business Overview
Table 22. GE Healthcare Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 23. GE Healthcare Product Portfolio
Table 24. GE Healthcare Recent Developments
Table 25. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Company Information
Table 26. Merck (Sigma-Aldrich) Business Overview
Table 27. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 28. Merck (Sigma-Aldrich) Product Portfolio
Table 29. Merck (Sigma-Aldrich) Recent Developments
Table 30. Moregate BioTech Bovine Blood Plasma Derivatives Company Information
Table 31. Moregate BioTech Business Overview
Table 32. Moregate BioTech Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 33. Moregate BioTech Product Portfolio
Table 34. Moregate BioTech Recent Developments
Table 35. Gemini Bovine Blood Plasma Derivatives Company Information
Table 36. Gemini Business Overview
Table 37. Gemini Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 38. Gemini Product Portfolio
Table 39. Gemini Recent Developments
Table 40. Atlanta Biologicals Bovine Blood Plasma Derivatives Company Information
Table 41. Atlanta Biologicals Business Overview
Table 42. Atlanta Biologicals Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 43. Atlanta Biologicals Product Portfolio
Table 44. Atlanta Biologicals Recent Developments
Table 45. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Company Information
Table 46. Tissue Culture Biologicals Business Overview
Table 47. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 48. Tissue Culture Biologicals Product Portfolio
Table 49. Tissue Culture Biologicals Recent Developments
Table 50. Bovogen Bovine Blood Plasma Derivatives Company Information
Table 51. Bovogen Business Overview
Table 52. Bovogen Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 53. Bovogen Product Portfolio
Table 54. Bovogen Recent Developments
Table 55. Biowest Bovine Blood Plasma Derivatives Company Information
Table 56. Biowest Business Overview
Table 57. Biowest Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 58. Biowest Product Portfolio
Table 59. Biowest Recent Developments
Table 60. Internegocios Bovine Blood Plasma Derivatives Company Information
Table 61. Internegocios Business Overview
Table 62. Internegocios Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 63. Internegocios Product Portfolio
Table 64. Internegocios Recent Developments
Table 65. RMBIO Bovine Blood Plasma Derivatives Company Information
Table 66. RMBIO Business Overview
Table 67. RMBIO Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 68. RMBIO Product Portfolio
Table 69. RMBIO Recent Developments
Table 70. Biological Industries Bovine Blood Plasma Derivatives Company Information
Table 71. Biological Industries Business Overview
Table 72. Biological Industries Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 73. Biological Industries Product Portfolio
Table 74. Biological Industries Recent Developments
Table 75. VWR Bovine Blood Plasma Derivatives Company Information
Table 76. VWR Business Overview
Table 77. VWR Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 78. VWR Product Portfolio
Table 79. VWR Recent Developments
Table 80. Corning Bovine Blood Plasma Derivatives Company Information
Table 81. Corning Business Overview
Table 82. Corning Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 83. Corning Product Portfolio
Table 84. Corning Recent Developments
Table 85. Corning Bovine Blood Plasma Derivatives Company Information
Table 86. Serana Business Overview
Table 87. Serana Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 88. Serana Product Portfolio
Table 89. Serana Recent Developments
Table 90. Lanzhou Minhai Bovine Blood Plasma Derivatives Company Information
Table 91. Lanzhou Minhai Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 92. Lanzhou Minhai Product Portfolio
Table 93. Lanzhou Minhai Recent Developments
Table 94. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Company Information
Table 95. Zhejiang Tianhang Biotechnology Business Overview
Table 96. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 97. Zhejiang Tianhang Biotechnology Product Portfolio
Table 98. Zhejiang Tianhang Biotechnology Recent Developments
Table 99. ExCell Bio Bovine Blood Plasma Derivatives Company Information
Table 100. ExCell Bio Business Overview
Table 101. ExCell Bio Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 102. ExCell Bio Product Portfolio
Table 103. ExCell Bio Recent Developments
Table 104. Jin Yuan Kang Bovine Blood Plasma Derivatives Company Information
Table 105. Jin Yuan Kang Business Overview
Table 106. Jin Yuan Kang Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 107. Jin Yuan Kang Product Portfolio
Table 108. Jin Yuan Kang Recent Developments
Table 109. American Protein Company Bovine Blood Plasma Derivatives Company Information
Table 110. American Protein Company Business Overview
Table 111. American Protein Company Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 112. American Protein Company Product Portfolio
Table 113. American Protein Company Recent Developments
Table 114. Sonac Bovine Blood Plasma Derivatives Company Information
Table 115. Sonac Business Overview
Table 116. Sonac Bovine Blood Plasma Derivatives Production Capacity (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2019-2024)
Table 117. Sonac Product Portfolio
Table 118. Sonac Recent Developments
Table 119. Global Bovine Blood Plasma Derivatives Production Comparison by Region: 2019 VS 2023 VS 2030 (K Liters)
Table 120. Global Bovine Blood Plasma Derivatives Production by Region (2019-2024) & (K Liters)
Table 121. Global Bovine Blood Plasma Derivatives Production Market Share by Region (2019-2024)
Table 122. Global Bovine Blood Plasma Derivatives Production Forecast by Region (2025-2030) & (K Liters)
Table 123. Global Bovine Blood Plasma Derivatives Production Market Share Forecast by Region (2025-2030)
Table 124. Global Bovine Blood Plasma Derivatives Production Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 125. Global Bovine Blood Plasma Derivatives Production Value by Region (2019-2024) & (US$ Million)
Table 126. Global Bovine Blood Plasma Derivatives Production Value Market Share by Region (2019-2024)
Table 127. Global Bovine Blood Plasma Derivatives Production Value Forecast by Region (2025-2030) & (US$ Million)
Table 128. Global Bovine Blood Plasma Derivatives Production Value Market Share Forecast by Region (2025-2030)
Table 129. Global Bovine Blood Plasma Derivatives Market Average Price (USD/L) by Region (2019-2024)
Table 130. Global Bovine Blood Plasma Derivatives Consumption Comparison by Region: 2019 VS 2023 VS 2030 (K Liters)
Table 131. Global Bovine Blood Plasma Derivatives Consumption by Region (2019-2024) & (K Liters)
Table 132. Global Bovine Blood Plasma Derivatives Consumption Market Share by Region (2019-2024)
Table 133. Global Bovine Blood Plasma Derivatives Forecasted Consumption by Region (2025-2030) & (K Liters)
Table 134. Global Bovine Blood Plasma Derivatives Forecasted Consumption Market Share by Region (2025-2030)
Table 135. North America Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Liters)
Table 136. North America Bovine Blood Plasma Derivatives Consumption by Country (2019-2024) & (K Liters)
Table 137. North America Bovine Blood Plasma Derivatives Consumption by Country (2025-2030) & (K Liters)
Table 138. Europe Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Liters)
Table 139. Europe Bovine Blood Plasma Derivatives Consumption by Country (2019-2024) & (K Liters)
Table 140. Europe Bovine Blood Plasma Derivatives Consumption by Country (2025-2030) & (K Liters)
Table 141. Asia Pacific Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Liters)
Table 142. Asia Pacific Bovine Blood Plasma Derivatives Consumption by Country (2019-2024) & (K Liters)
Table 143. Asia Pacific Bovine Blood Plasma Derivatives Consumption by Country (2025-2030) & (K Liters)
Table 144. Latin America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K Liters)
Table 145. Latin America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Country (2019-2024) & (K Liters)
Table 146. Latin America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Country (2025-2030) & (K Liters)
Table 147. Global Bovine Blood Plasma Derivatives Production by Type (2019-2024) & (K Liters)
Table 148. Global Bovine Blood Plasma Derivatives Production by Type (2025-2030) & (K Liters)
Table 149. Global Bovine Blood Plasma Derivatives Production Market Share by Type (2019-2024)
Table 150. Global Bovine Blood Plasma Derivatives Production Market Share by Type (2025-2030)
Table 151. Global Bovine Blood Plasma Derivatives Production Value by Type (2019-2024) & (US$ Million)
Table 152. Global Bovine Blood Plasma Derivatives Production Value by Type (2025-2030) & (US$ Million)
Table 153. Global Bovine Blood Plasma Derivatives Production Value Market Share by Type (2019-2024)
Table 154. Global Bovine Blood Plasma Derivatives Production Value Market Share by Type (2025-2030)
Table 155. Global Bovine Blood Plasma Derivatives Price by Type (2019-2024) & (USD/L)
Table 156. Global Bovine Blood Plasma Derivatives Price by Type (2025-2030) & (USD/L)
Table 157. Global Bovine Blood Plasma Derivatives Production by Application (2019-2024) & (K Liters)
Table 158. Global Bovine Blood Plasma Derivatives Production by Application (2025-2030) & (K Liters)
Table 159. Global Bovine Blood Plasma Derivatives Production Market Share by Application (2019-2024)
Table 160. Global Bovine Blood Plasma Derivatives Production Market Share by Application (2025-2030)
Table 161. Global Bovine Blood Plasma Derivatives Production Value by Application (2019-2024) & (US$ Million)
Table 162. Global Bovine Blood Plasma Derivatives Production Value by Application (2025-2030) & (US$ Million)
Table 163. Global Bovine Blood Plasma Derivatives Production Value Market Share by Application (2019-2024)
Table 164. Global Bovine Blood Plasma Derivatives Production Value Market Share by Application (2025-2030)
Table 165. Global Bovine Blood Plasma Derivatives Price by Application (2019-2024) & (USD/L)
Table 166. Global Bovine Blood Plasma Derivatives Price by Application (2025-2030) & (USD/L)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings